These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

871 related articles for article (PubMed ID: 9641558)

  • 1. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid.
    Miranda AF; Boegman RJ; Beninger RJ; Jhamandas K
    Neuroscience; 1997 Jun; 78(4):967-75. PubMed ID: 9174065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
    Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
    Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
    Guidetti P; Wu HQ; Schwarcz R
    Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinolinic acid lesion of the nigrostriatal pathway: effect on turning behaviour and protection by elevation of endogenous kynurenic acid in Rattus norvegicus.
    Miranda AF; Sutton MA; Beninger RJ; Jhamandas K; Boegman RJ
    Neurosci Lett; 1999 Mar; 262(2):81-4. PubMed ID: 10203236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats.
    Nozaki K; Beal MF
    J Cereb Blood Flow Metab; 1992 May; 12(3):400-7. PubMed ID: 1569135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease.
    Sapko MT; Guidetti P; Yu P; Tagle DA; Pellicciari R; Schwarcz R
    Exp Neurol; 2006 Jan; 197(1):31-40. PubMed ID: 16099455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
    Pérez-De La Cruz V; González-Cortés C; Galván-Arzate S; Medina-Campos ON; Pérez-Severiano F; Ali SF; Pedraza-Chaverrí J; Santamaría A
    Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. l-kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleus.
    Vámos E; Párdutz A; Varga H; Bohár Z; Tajti J; Fülöp F; Toldi J; Vécsei L
    Neuropharmacology; 2009 Sep; 57(4):425-9. PubMed ID: 19580819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spermine attenuates behavioral and biochemical alterations induced by quinolinic acid in the striatum of rats.
    Velloso NA; Dalmolin GD; Fonini G; Gindri Sinhorin VD; Ferreira da Silveira A; Rubin MA; Mello CF
    Brain Res; 2008 Mar; 1198():107-14. PubMed ID: 18243165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity.
    Orlando LR; Alsdorf SA; Penney JB; Young AB
    Exp Neurol; 2001 Jan; 167(1):196-204. PubMed ID: 11161608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of dapsone against quinolinate- and kainate-induced striatal neurotoxicities in rats.
    Santamaría A; Ordaz-Moreno J; Rubio-Osornio M; Solís-Hernández F; Ríos C
    Pharmacol Toxicol; 1997 Dec; 81(6):271-5. PubMed ID: 9444668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemically administered glucosamine-kynurenic acid, but not pure kynurenic acid, is effective in decreasing the evoked activity in area CA1 of the rat hippocampus.
    Robotka H; Németh H; Somlai C; Vécsei L; Toldi J
    Eur J Pharmacol; 2005 Apr; 513(1-2):75-80. PubMed ID: 15878711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of quinolinic and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine.
    Moroni F; Russi P; Gallo-Mezo MA; Moneti G; Pellicciari R
    J Neurochem; 1991 Nov; 57(5):1630-5. PubMed ID: 1833509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus.
    Carrillo-Mora P; Méndez-Cuesta LA; Pérez-De La Cruz V; Fortoul-van Der Goes TI; Santamaría A
    Behav Brain Res; 2010 Jul; 210(2):240-50. PubMed ID: 20219555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synergism of picrotoxin with the endogenous convulsants kynurenine and quinolinic acid and its antagonism with their antagonists].
    Lapin IP; Ryzhov IV
    Farmakol Toksikol; 1985; 48(6):13-7. PubMed ID: 3002845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activities.
    Carpenedo R; Chiarugi A; Russi P; Lombardi G; Carlà V; Pellicciari R; Mattoli L; Moroni F
    Neuroscience; 1994 Jul; 61(2):237-43. PubMed ID: 7969905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions.
    Beal MF; Kowall NW; Swartz KJ; Ferrante RJ; Martin JB
    Synapse; 1989; 3(1):38-47. PubMed ID: 2563916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration.
    Bazzett TJ; Becker JB; Kaatz KW; Albin RL
    Exp Neurol; 1993 Apr; 120(2):177-85. PubMed ID: 8387931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of peripheral loading with kynurenine and probenecid on extracellular striatal kynurenic acid concentrations.
    Miller JM; MacGarvey U; Beal MF
    Neurosci Lett; 1992 Oct; 146(1):115-8. PubMed ID: 1475044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.